RPG Life Sciences P/E Ratio
RPG Life Sciences (RPGLIFE) P/E ratio is 38.4 (High), EPS (TTM) ₹69.64, current price ₹2802.40 on NSE vs historical average P/E of 17.93 (100.0th percentile) — Very High - High growth expectations or significantly overvalued.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
RPGLIFE P/E Ratio — Valuation Signal & Historical Context
RPG Life Sciences P/E 38.4 vs historical average 17.93, range 17.93–17.93 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see RPGLIFE screener.
- Stock appears overvalued with PE of 38.4, suggesting caution for new investments
- Current PE is 114.2% above historical average
- Trading at discount to sector average PE of 56.89
RPG Life Sciences P/E Ratio Historical Trend
RPGLIFE annual price-to-earnings ratio — 1 years, EPS and year-end price. Current P/E 38.4 vs historical average 17.93. Also explore RPGLIFE share price charts to track price trends across different timeframes.
RPGLIFE Historical P/E Ratio — EPS, Year-End Price & Valuation
RPG Life Sciences annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 17.93 | 122.52 | ₹2196.55 | NSE | Moderate |
RPGLIFE vs Healthcare Peers — P/E Ratio Comparison
RPG Life Sciences P/E 38.4 vs Healthcare average 56.89, median 31.66 — range 1.99–747.21.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 1.99 | ₹66 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Colinz Laboratories | COLINZ | 3.27 | ₹9 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.03 | ₹6,361 | Low |
| Dipna Pharmachem | DPL | 4.65 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.95 | ₹67 | Low |
| Shelter Pharma | SHELTER | 5.71 | ₹56 | Low |
| GKB Ophthalmics | GKB | 5.9 | ₹33 | Low |
| Kabra Drugs | KABRADG | 6.29 | ₹49 | Low |